SSA
HIMS icon

Schonfeld Strategic Advisors’s Hims & Hers Health HIMS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,393
Closed -$191K – 2164
2024
Q3 		$191K Sell
10,393
-6,019
-37% -$108K ﹤0.01% 1820
2024
Q2 		$331K Sell
16,412
-1,934
-11% -$32.2K ﹤0.01% 1642
2024
Q1 		$284K Buy
+18,346
New +$207K ﹤0.01% 1671
2023
Q4 		– Sell
-91,100
Closed -$573K – 2015
2023
Q3 		$573K Sell
91,100
-36,913
-29% -$275K ﹤0.01% 1173
2023
Q2 		$1.2M Sell
128,013
-45,887
-26% -$455K 0.01% 915
2023
Q1 		$1.73M Sell
173,900
-85,062
-33% -$745K 0.02% 735
2022
Q4 		$1.66M Buy
258,962
+103,559
+67% +$590K 0.01% 906
2022
Q3 		$868K Buy
155,403
+77,003
+98% +$464K 0.01% 1359
2022
Q2 		$355K Sell
78,400
-153,331
-66% -$654K ﹤0.01% 1557
2022
Q1 		$1.24M Buy
+231,731
New +$1.15M 0.01% 893
2021
Q2 		– Sell
-70,342
Closed -$932K – 2090
2021
Q1 		$932K Buy
+70,342
New +$1.18M 0.01% 928

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schonfeld Strategic Advisors's HIMS Position: Q4 2024 in Review

Schonfeld Strategic Advisors sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 10,393 shares — an estimated $191K sold.

Schonfeld Strategic Advisors first reported a position in HIMS in Q1 2021 and held it in 11 quarters. The position peaked at $1.73M in Q1 2023. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Schonfeld Strategic Advisors reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,393 Hims & Hers Health shares in Q4 2024, an estimated $191K.
  • Schonfeld Strategic Advisors first reported a position in Hims & Hers Health in Q1 2021 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Hims & Hers Health position peaked at $1.73M in Q1 2023.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.